Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice

Huiying Gu, Zhizhong Ma, Jian Wang, Timothy Zhu, Nicole Du, Adam Shatara, Xin Yi, Mark C. Kowala, Yansheng Du

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hypertension is one of the most important, preventable causes of premature morbidity and mortality in the developed world. Aldosterone is a major mineralocorticoid hormone that plays a key role in the regulation of blood pressure and is implicated in the pathogenesis of hypertension and heart failure. Aldosterone synthase (AS, cytochrome P450 11B2, cyp11B2) is the sole enzyme responsible for the production of aldosterone in humans. To determine the effects of increased expression of human aldosterone synthase (hAS) on blood pressure (BP), we established transgenic mice carrying the hAS gene (cyp11B2). We showed that hAS overexpression increased levels of aldosterone in hAS+/- mice. On high salt diet (HS), BPs of hAS+/- mice were significantly increased compared with WT mice. Fadrozole (an inhibitor of aldosterone synthase) treatment significantly reduced BPs of hAS+/- mice on HS. This is the first time overexpression of AS in a transgenic mouse line has shown an ability to induce HP. Specifically inhibiting AS activity in these mice is a promising therapy for reducing hypertension. This hAS transgenic mouse model is therefore an ideal animal model for hypertension therapy studies.

Original languageEnglish (US)
Article number00461
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Cytochrome P-450 CYP11B2
Transgenic Mice
Salts
Blood Pressure
Aldosterone
Hypertension
Fadrozole
Diet
Mineralocorticoids
Premature Mortality

ASJC Scopus subject areas

  • General

Cite this

Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice. / Gu, Huiying; Ma, Zhizhong; Wang, Jian; Zhu, Timothy; Du, Nicole; Shatara, Adam; Yi, Xin; Kowala, Mark C.; Du, Yansheng.

In: Scientific Reports, Vol. 7, No. 1, 00461, 01.12.2017.

Research output: Contribution to journalArticle

Gu, H, Ma, Z, Wang, J, Zhu, T, Du, N, Shatara, A, Yi, X, Kowala, MC & Du, Y 2017, 'Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice', Scientific Reports, vol. 7, no. 1, 00461. https://doi.org/10.1038/s41598-017-00461-9
Gu, Huiying ; Ma, Zhizhong ; Wang, Jian ; Zhu, Timothy ; Du, Nicole ; Shatara, Adam ; Yi, Xin ; Kowala, Mark C. ; Du, Yansheng. / Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{23eb26be11e843d3b8328a1371b7ff40,
title = "Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice",
abstract = "Hypertension is one of the most important, preventable causes of premature morbidity and mortality in the developed world. Aldosterone is a major mineralocorticoid hormone that plays a key role in the regulation of blood pressure and is implicated in the pathogenesis of hypertension and heart failure. Aldosterone synthase (AS, cytochrome P450 11B2, cyp11B2) is the sole enzyme responsible for the production of aldosterone in humans. To determine the effects of increased expression of human aldosterone synthase (hAS) on blood pressure (BP), we established transgenic mice carrying the hAS gene (cyp11B2). We showed that hAS overexpression increased levels of aldosterone in hAS+/- mice. On high salt diet (HS), BPs of hAS+/- mice were significantly increased compared with WT mice. Fadrozole (an inhibitor of aldosterone synthase) treatment significantly reduced BPs of hAS+/- mice on HS. This is the first time overexpression of AS in a transgenic mouse line has shown an ability to induce HP. Specifically inhibiting AS activity in these mice is a promising therapy for reducing hypertension. This hAS transgenic mouse model is therefore an ideal animal model for hypertension therapy studies.",
author = "Huiying Gu and Zhizhong Ma and Jian Wang and Timothy Zhu and Nicole Du and Adam Shatara and Xin Yi and Kowala, {Mark C.} and Yansheng Du",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-00461-9",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice

AU - Gu, Huiying

AU - Ma, Zhizhong

AU - Wang, Jian

AU - Zhu, Timothy

AU - Du, Nicole

AU - Shatara, Adam

AU - Yi, Xin

AU - Kowala, Mark C.

AU - Du, Yansheng

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Hypertension is one of the most important, preventable causes of premature morbidity and mortality in the developed world. Aldosterone is a major mineralocorticoid hormone that plays a key role in the regulation of blood pressure and is implicated in the pathogenesis of hypertension and heart failure. Aldosterone synthase (AS, cytochrome P450 11B2, cyp11B2) is the sole enzyme responsible for the production of aldosterone in humans. To determine the effects of increased expression of human aldosterone synthase (hAS) on blood pressure (BP), we established transgenic mice carrying the hAS gene (cyp11B2). We showed that hAS overexpression increased levels of aldosterone in hAS+/- mice. On high salt diet (HS), BPs of hAS+/- mice were significantly increased compared with WT mice. Fadrozole (an inhibitor of aldosterone synthase) treatment significantly reduced BPs of hAS+/- mice on HS. This is the first time overexpression of AS in a transgenic mouse line has shown an ability to induce HP. Specifically inhibiting AS activity in these mice is a promising therapy for reducing hypertension. This hAS transgenic mouse model is therefore an ideal animal model for hypertension therapy studies.

AB - Hypertension is one of the most important, preventable causes of premature morbidity and mortality in the developed world. Aldosterone is a major mineralocorticoid hormone that plays a key role in the regulation of blood pressure and is implicated in the pathogenesis of hypertension and heart failure. Aldosterone synthase (AS, cytochrome P450 11B2, cyp11B2) is the sole enzyme responsible for the production of aldosterone in humans. To determine the effects of increased expression of human aldosterone synthase (hAS) on blood pressure (BP), we established transgenic mice carrying the hAS gene (cyp11B2). We showed that hAS overexpression increased levels of aldosterone in hAS+/- mice. On high salt diet (HS), BPs of hAS+/- mice were significantly increased compared with WT mice. Fadrozole (an inhibitor of aldosterone synthase) treatment significantly reduced BPs of hAS+/- mice on HS. This is the first time overexpression of AS in a transgenic mouse line has shown an ability to induce HP. Specifically inhibiting AS activity in these mice is a promising therapy for reducing hypertension. This hAS transgenic mouse model is therefore an ideal animal model for hypertension therapy studies.

UR - http://www.scopus.com/inward/record.url?scp=85016985595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016985595&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-00461-9

DO - 10.1038/s41598-017-00461-9

M3 - Article

C2 - 28352088

AN - SCOPUS:85016985595

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 00461

ER -